Trazpiroben

DB18794InvestigationalSmall molecule

Trazpiroben: Overview.

Mechanism: Pharmacologically active on Dopamine receptor D2 and Dopamine receptor D3
Curator reviewed
Formula / weight: C₃₁H₃₉N₃O₄ · 517.67 g/mol (avg)
Code names: TAK-906

Resolves to

Compound

Structure

InChIKeyBDXJYAAYLZTLEK-UHFFFAOYSA-NSMILESOC(=O)C1=CC=CC(CN2CN(C3CCCCC3)C3(CCN(CCCC(=O)C4=CC=CC=C4)CC3)C2=O)=C1

Targets

What you can answer from here — as of August 30, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

5Clinical trialsPhase, status and sponsor resolved per trial

6+ReferencesStructured and connected to the statements they support

Which drugs share a target with Trazpiroben, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.